Long-term Follow-up
Long-term Follow-up is an intervention with 8 clinical trials. Currently 4 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
4
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Outcome of Cardiac Arrest Survivors
Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls
Long-Term Follow-Up in Patients With Prostate Cancer After Surgery
Long Term Follow-Up in Patients With Stage 0-IIIC Breast Cancer
Long-Term Side Effects of Ruxolitinib in Treating Patients With Myelofibrosis
Clinical Trials (8)
Outcome of Cardiac Arrest Survivors
Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated Controls
Long-Term Follow-Up in Patients With Prostate Cancer After Surgery
Long Term Follow-Up in Patients With Stage 0-IIIC Breast Cancer
Long-Term Side Effects of Ruxolitinib in Treating Patients With Myelofibrosis
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
Novel Subtypes of Polycystic Ovary Syndrome
Long-term Follow-Up for RGX-121
All 8 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 8